Cervical Cancer Clinical Trials

Find Cervical Cancer Clinical Trials Near You

Accelerating Adoption of Patient-centered Cervical Cancer Screening and Treatment Linkage in Kenya

Status: Recruiting
Location: See location...
Intervention Type: Behavioral
Study Type: Interventional
Study Phase: Not Applicable
SUMMARY

This study aims to test the use of a multi-component care strategy (DADA LINK) designed to improve cervical cancer screening and linkage to treatment. The duration of the trial is 12 months, with a 6-month follow-up period to evaluate intervention costs and measure maintenance of the care strategies. Study staff at each clinic will abstract data on cervical cancer screening and triage/treatment. Clinics randomized to the intervention arm will have care coordinators who motivate clinic staff to adhere to cervical cancer care guidelines, conduct patient exit surveys to assess intervention fidelity, and support care coordination through use of the mHealth platform (WEMA).

Eligibility
Participation Requirements
Sex: Female
Minimum Age: 25
Maximum Age: 49
Healthy Volunteers: t
View:

• \- Women ages 25-49 years

Locations
Other Locations
Kenya
Kenyatta National Hospital
RECRUITING
Nairobi
Contact Information
Primary
Agnes K Karume, MBChB, MBA, MPH
karumeagnes@gmail.com
+254715181283
Backup
Millicent Masinde, MBChB, MMed, Fell.Gyn Oncology
dr.msmillies@gmail.com
+254721243740
Time Frame
Start Date: 2025-12-01
Estimated Completion Date: 2026-12
Participants
Target number of participants: 1980
Treatments
Experimental: DADA-LINK Integrated Care Package: HPV Self-Sampling, Care Navigation, and mHealth support
Intervention facilities will receive the DADA-LINK multi-component integrated care package comprised of HPV self-sampling, care navigation, and mHealth support.
No_intervention: Routine standard of care for cervical cancer screening, linkage and treatment
Clinics randomized to the control arm will continue with usual care practices for cervical cancer screening, triage, and treatment
Related Therapeutic Areas
Sponsors
Collaborators: University of Washington, Emory University, Queen's University, National Cancer Institute (NCI), University of Nairobi, Kenya Ministry of Health
Leads: Kenyatta National Hospital

This content was sourced from clinicaltrials.gov